AlfaKinetic
by Anervea
LandscapeMonitorCompareProfileAsk
principle

Nothing is shown without a source. When the data can’t answer, the product says so.

LB Pharmaceuticals
tenant
drug

MINI-KID

as of 2026-07-01
Add to landscapeMonitor thisCompare thisAsk about this
at a glance
OTHER
Pre-approval / investigational in the US
Developed by University of South Florida
1 trials in the graph
Synthesized from structured facts only — each point cited above.

Mechanism & identity

Modality
OTHER

Indications

Investigational (via trials)
Substance-Related DisordersPervasive Developmental DisorderMajor DepressionOppositional Defiant DisorderEating DisordersAlcoholismADHDAlcohol DependenceDrug DependenceSuicidal IdeationDysthymiaAnxiety DisordersDepressive Disorder, MajorAttention Deficit Disorder with HyperactivitySuicidalityFeeding and Eating Disorders

Trials

1
Reliability and Validity of the MINI International Neuropsychiatric Interview for Children and Adolescents (MINI-KID)
NCT00579267—Completed

KOLs & investigators

1
David V. Sheehan, MD, MBA

Facts & assertions

0 sourced
No assertions recorded for this entity.
relationships
The graph out of here
developer
University of South Florida
company
trial
Reliability and Validity of the MINI International Neuropsychiatric Interview for Children and Adolescents (MINI-KID)
trial
indication
Substance-Related Disorders
indication
Pervasive Developmental Disorder
indication
Major Depression
indication
Oppositional Defiant Disorder
indication
KOL
David V. Sheehan, MD, MBA
KOL score —
person